Phase I study of 9-ing-41, a small molecule selective glycogen synthase kinase-3 beta (GSK-3 ) inhibitor, as a single agent and combined with chemotherapy, in patients with refractory tumors.
9-ING-41
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Phase I study of 9-ing-41, a small molecule selective glycogen synthase kinase-3 beta (GSK-3 ) inhibitor, as a single agent and combined with chemotherapy, in patients with refractory tumors. ### Output: 9-ING-41